Adlai Nortye Ltd. Sponsored ADR (ANL) vs Jade Biosciences, Inc. (JBIO)

Adlai Nortye Ltd. Sponsored ADR and Jade Biosciences, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Jade Biosciences, Inc. are of similar size ($936.8M and $929.7M). Across the 7 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 4 and Jade Biosciences, Inc. on 3.

Valuation

Metric ANL JBIO Biotechnology median
P/E — n/m 7.88
P/S — n/m 11.47
P/B n/m 2.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield — (13.31%) (28.84%)
Free cash flow yield 0.00% (14.06%) (23.03%)

Profitability

Metric ANL JBIO Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (39.27%) (57.72%)
Return on assets 0.00% (36.19%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANL JBIO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 31.48% 78.57% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL JBIO Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 9.55 14.93 4.73
Net debt to EBITDA (0.05) 2.94 0.96

Dividend

Metric ANL JBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ANL JBIO Biotechnology median
Market cap 929.70m 936.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack